ID   SpEBr-5
AC   CVCL_JX60
SY   spEBR-5
DR   Wikidata; Q54955539
RX   PubMed=7900209;
RX   PubMed=14678650;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI:4883; Ethidium bromide.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
RX   PubMed=7900209;
RA   Berezkina E.V., Lipskaia L.A., Grinchuk T.M., Kovaleva Z.V.,
RA   Sorokina E.A., Vasiukhin V.I., Ignatova T.N.;
RT   "The isolation and genetic characteristics of the new cell line of
RT   mouse myeloma spEBR-5 selected for ethidium bromide resistance and
RT   characterized by multiple drug resistance.";
RL   Tsitologiia 36:687-695(1994).
//
RX   PubMed=14678650; DOI=10.1089/153685903322538854;
RA   Melixetian M.B., Pavlenko M.A., Beriozkina E.V., Kovaleva Z.V.,
RA   Sorokina E.A., Ignatova T.N., Grinchuk T.M.;
RT   "Mouse myeloma cell line Sp2/0 multidrug-resistant variant as parental
RT   cell line for hybridoma construction.";
RL   Hybrid. Hybridomics 22:321-327(2003).
//